The Effects on Ovarian Function of The Combination of Methotrexate and Iguratimod in Women Suffering from Moderate to Severe Active Rheumatoid Arthritis
Archives of Immunology Research and Therapy · 2024
DOI: 10.58489/2836-5003/013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Immunology Research and Therapy, 2024. Verfasst von Hira Ashiq und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a common autoimmune disease that causes stiffness, pain, and swelling in the joints in the morning. If the disease gets worse, the joints can become deformed. This can make it harder for joints to work normally, which can have a big effect on the patient's daily life and quality of life. The main drug used to treat rheumatoid arthritis (RA) is methotrexate (MTX). As an immunosuppressant, it stops B cells from activating incorrectly in the body, stops the production of cytokines that aren't supposed to be there, and eases the symptoms that come with that. However, some cases have shown that using MTX by itself is not the best way to treat pain; it usually needs to be combined with other medicines. Iguratimod (IGU) is a new disease-modifying antirheumatic drug (DMARD) that can reduce inflammation and change the immune system. This is a small molecule drug made from 7-methanesulfonylamino-6-phenoxychromones. It has two amide groups. The purpose of this study was to find out how well MTX and IGU work together as a treatment choice for women with mild to severe RA. It also looked into how this medicine changes the way ovaries work, which gives doctors a medical basis for making decisions about clinical care.
Zitieren
APA
Ashiq, H., Fatima, Z., Masood, B., Tanveer, L., Arshad, E., & Rauf, S. (2024). The Effects on Ovarian Function of The Combination of Methotrexate and Iguratimod in Women Suffering from Moderate to Severe Active Rheumatoid Arthritis. Archives of Immunology Research and Therapy. https://doi.org/10.58489/2836-5003/013
Vancouver
Ashiq H, Fatima Z, Masood B, Tanveer L, Arshad E, Rauf S. The Effects on Ovarian Function of The Combination of Methotrexate and Iguratimod in Women Suffering from Moderate to Severe Active Rheumatoid Arthritis. Archives of Immunology Research and Therapy. 2024. doi:10.58489/2836-5003/013
BibTeX
@article{Ashiq2024,
author = {Ashiq, Hira and Fatima, Zahra and Masood, Bushra and Tanveer, Laiba and Arshad, Emania and Rauf, Shaista},
title = {The Effects on Ovarian Function of The Combination of Methotrexate and Iguratimod in Women Suffering from Moderate to Severe Active Rheumatoid Arthritis},
journal = {Archives of Immunology Research and Therapy},
year = {2024},
doi = {10.58489/2836-5003/013}
}
EUVIMED